March 1 (Reuters) - Surgical imaging devices maker IMRIS Inc posted a fourth-quarter loss, hurt in part by delayed product installations.
The company expects 2012 revenue of $57 million to $60 million. The company also expects first-quarter revenue of about $4 million.
At Dec. 31, IMRIS’s backlog was $95 million.
For October-December the company lost $5 million, or 11 cents a share, compared with a profit of $970,000, or 2 cents a share, a year ago.
Revenue fell about 41 percent to $14.7 million.
Shares of the company closed at C$2.67 on the Toronto Stock Exchange, while its U.S.-listed shares closed at $2.70 on the Nasdaq.